Body dysmorphic disorder (BDD)

Presse Medicale

Volumn 41, Issue 1, 2012, Pages

  Tignol, Jean ^a   Martin Guehl, Corinne ^a   Aouizerzate, Bruno ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

ARTICLE; BODY DYSMORPHIC DISORDER; COGNITIVE THERAPY; DELUSION; DISEASE SEVERITY; HUMAN; PREVALENCE; SAFETY; BODY IMAGE; COMORBIDITY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; PLASTIC SURGERY; REVIEW; SOCIAL ENVIRONMENT; SOMATOFORM DISORDER; UTILIZATION REVIEW;

BODY DYSMORPHIC DISORDERS; BODY IMAGE; COGNITIVE THERAPY; COMORBIDITY; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; HUMANS; PREVALENCE; SOCIAL ENVIRONMENT; SOMATOFORM DISORDERS; SURGERY, PLASTIC;

EID: 84855495235     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2011.05.021     Document Type: Article

References (131)

1. Tignol J. Les défauts physiques imaginaires 2006, Odile Jacob, Paris.
2. Andreasen N.C., Bardach J. Dysmorphophobia: symptom or disease?. Am J Psychiatry 1977, 134(6):673-676.
3. Thomas C.S. Dysmorphophobia: a question of definition. Br J Psychiatry 1984, 144:513-516.
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (Rev 3rd ed.). Washington DC: APA; 1987.
5. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994.
6. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Text Revision. Washington, DC: American Psychiatric Association; 2000.
7. CIM-10. Classification internationale des troubes mentaux et des troubles du comportement. Descriptions cliniques et directives pour le diagnostic. Genève/Paris: OMS/Masson; 1992.
8. CIM-10. Classification internationale des troubes mentaux et des troubles du comportement. Critères diagnostiques pour la recherche. Genève/Paris: OMS/Masson; 1993.
9. Phillips K.A. The broken mirror: understanding and treating body dysmorphic disorder 1996, Oxford University Press, New York.
10. Phillips K.A., Menard W., Fay C. Gender similarities and differences in 200individuals with body dysmorphic disorder. Compr Psychiatry 2006, 47(2):77-87.
11. Pope H.G., Gruber A.J., Choi P., Olivardia R., Phillips K.A. Muscle dysmorphia. An underrecognized form of body dysmorphic disorder. Psychosomatics 1997, 38(6):548-557.
12. Atiullah N., Phillips K.A. Fatal body dysmorphic disorder by proxy. J Clin Psychiatry 2001, 62(3):204-205.
13. Phillips K.A., McElroy S.L. Insight, overvalued ideation, and delusional thinking in body dysmorphic disorder: theoretical and treatment implications. J Nerv Ment Dis 1993, 181(11):699-702.
14. Phillips K.A., McElroy S.L., Keck P.E., Hudson J.I., Pope H.G. A comparison of delusional and nondelusional body dysmorphic disorder in 100cases. Psychopharmacol Bull 1994, 30(2):179-186.
15. Eisen J.L., Phillips K.A., Baer L., Beer D.A., Atala K.D., Rasmussen S.A. The brown assessment of beliefs scale: reliability and validity. Am J Psychiatry 1998, 155(1):102-108.
16. Phillips K.A., Menard W., Pagano M.E., Fay C., Stout R.L. Delusional versus nondelusional body dysmorphic disorder: clinical features and course of illness. J Psychiatr Res 2006, 40(2):95-104.
17. Hollander E., Liebowitz M.R., Winchel R., Klumker A., Klein D.F. Treatment of body dysmorphic disorder with serotonin reuptake blockers. Am J Psychiatry 1989, 146(6):768-770.
18. Phillips K.A., McElroy S.L., Dwight M.M., Eisen J.L., Rasmussen S.A. Delusionality and response to open-label fluvoxamine in body dysmorphic disorder. J Clin Psychiatry 2001, 62(2):87-91.
19. Phillips K.A., Didie E.R., Menard W., Pagano M.E., Fay C., Weisberg R.B. Clinical features of body dysmorphic disorder in adolescents and adults. Psychiatry Res 2006, 141(3):305-314.
20. Phillips K.A., Pagano M.E., Menard W., Stout R.L. A 12-month follow-up study of the course of body dysmorphic disorder. Am J Psychiatry 2006, 163(5):907-912.
21. Phillips K.A., Quinn G., Stout R.L. Functional impairment in body dysmorphic disorder: a prospective, follow-up study. J Psychiatr Res 2008, 42(9):701-707.
22. Gunstad J., Phillips K.A. Axis I comorbidity in body dysmorphic disorder. Compr Psychiatry 2003, 44(4):270-276.
23. Phillips K.A., Stout R.L. Associations in the longitudinal course of body dysmorphic disorder with major depression, obsessive-compulsive disorder, and social phobia. J Psychiatr Res 2006, 40(4):360-369.
24. Coles M.E., Phillips K.A., Menard W., Pagano M.E., Fay C., Weisberg R.B., et al. Body dysmorphic disorder and social phobia: cross-sectional and prospective data. Depress Anxiety 2006, 23(1):26-33.
25. Grant J.E., Menard W., Pagano M.E., Fay C., Phillips K.A. Substance use disorders in individuals with body dysmorphic disorder. J Clin Psychiatry 2005, 66(3):309-316. [quiz 404-405].
26. Didie E.R., Menard W., Stern A.P., Phillips K.A. Occupational functioning and impairment in adults with body dysmorphic disorder. Compr Psychiatry 2008, 49(6):561-569.
27. Phillips K.A., Menard W. Suicidality in body dysmorphic disorder: a prospective study. Am J Psychiatry 2006, 163(7):1280-1282.
28. Phillips K.A., Kelly M.M. Suicidality in a placebo-controlled fluoxetine study of body dysmorphic disorder. Int Clin Psychopharmacol 2009, 24(1):26-28.
29. McLaughlin J.K., Wise T.N., Lipworth L. Increased risk of suicide among patients with breast implants: do the epidemiologic data support psychiatric consultation?. Psychosomatics 2004, 45(4):277-280.
30. Villeneuve P.J., Holowaty E.J., Brisson J., Xie L., Ugnat A.M., Latulippe L., et al. Mortality among Canadian women with cosmetic breast implants. Am J Epidemiol 2006, 164(4):334-341.
31. Lipworth L., Nyren O., Ye W., Fryzek J.P., Tarone R.E., McLaughlin J.K. Excess mortality from suicide and other external causes of death among women with cosmetic breast implants. Ann Plast Surg 2007, 59(2):119-123. [discussion 24-25].
32. Didie E.R., Phillips K.A. Re: " Mortality among Canadian women with cosmetic breast implants" Am J Epidemiol 2007, 165(7):846. [author reply: 7].
33. Klesmer J. Mortality in Swedish women with cosmetic breast implants: body dysmorphic disorder should be considered. BMJ 2003, 326(7401):1266-1267.
34. Phillips K.A. Body dysmorphic disorder: the distress of imagined ugliness. Am J Psychiatry 1991, 148(9):1138-1149.
35. Braga R.J., Mendlowicz M.V., Marrocos R.P., Figueira I.L. Anxiety disorders in outpatients with schizophrenia: prevalence and impact on the subjective quality of life. J Psychiatr Res 2005, 39(4):409-414.
36. Devulapalli K.K., Welge J.A., Nasrallah H.A. Temporal sequence of clinical manifestation in schizophrenia with comorbid OCD: review and meta-analysis. Psychiatry Res 2008, 161(1):105-108.
37. Faragian S., Pashinian A., Fuchs C., Poyurovsky M. Obsessive-compulsive symptom dimensions in schizophrenia patients with comorbid obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33(6):1009-1012.
38. Aouizerate B., Pujol H., Grabot D., Faytout M., Suire K., Braud C., et al. Body dysmorphic disorder in a sample of cosmetic surgery applicants. Eur Psychiatry 2003, 18(7):365-368.
39. de Jongh A., Adair P. Mental disorders in dental practice: a case report of body dysmorphic disorder. Spec Care Dentist 2004, 24(2):61-64.
40. Hepburn S., Cunningham S. Body dysmorphic disorder in adult orthodontic patients. Am J Orthod Dentofacial Orthop 2006, 130(5):569-574.
41. Phillips K.A., Conroy M., Dufresne R.G., Menard W., Didie E.R., Hunter-Yates J., et al. Tanning in body dysmorphic disorder. Psychiatr Q 2006, 77(2):129-138.
42. Phillips K.A., Dufresne R.G., Wilkel C.S., Vittorio C.C. Rate of body dysmorphic disorder in dermatology patients. J Am Acad Dermatol 2000, 42(3):436-441.
43. Sarwer D.B., Crerand C.E. Body dysmorphic disorder and appearance enhancing medical treatments. Body Image 2008, 5(1):50-58.
44. Vulink N.C., Rosenberg A., Plooij J.M., Koole R., Berge S.J., Denys D. Body dysmorphic disorder screening in maxillofacial outpatients presenting for orthognathic surgery. Int J Oral Maxillofac Surg 2008, 37(11):985-991.
45. Wilson J.B., Arpey C.J. Body dysmorphic disorder: suggestions for detection and treatment in a surgical dermatology practice. Dermatol Surg 2004, 30(11):1391-1399.
46. Conroy M., Menard W., Fleming-Ives K., Modha P., Cerullo H., Phillips K.A. Prevalence and clinical characteristics of body dysmorphic disorder in an adult inpatient setting. Gen Hosp Psychiatry 2008, 30(1):67-72.
47. Dyl J., Kittler J., Phillips K.A., Hunt J.I. Body dysmorphic disorder and other clinically significant body image concerns in adolescent psychiatric inpatients: prevalence and clinical characteristics. Child Psychiatry Hum Dev 2006, 36(4):369-382.
48. Grant J.E., Kim S.W., Crow S.J. Prevalence and clinical features of body dysmorphic disorder in adolescent and adult psychiatric inpatients. J Clin Psychiatry 2001, 62(7):517-522.
49. Brawman-Mintzer O., Lydiard R.B., Phillips K.A., Morton A., Czepowicz V., Emmanuel N., et al. Body dysmorphic disorder in patients with anxiety disorders and major depression: a comorbidity study. Am J Psychiatry 1995, 152(11):1665-1667.
50. Grant J.E., Kim S.W., Eckert E.D. Body dysmorphic disorder in patients with anorexia nervosa: prevalence, clinical features, and delusionality of body image. Int J Eat Disord 2002, 32(3):291-300.
51. Bienvenu O.J., Samuels J.F., Riddle M.A., Hoehn-Saric R., Liang K.Y., Cullen B.A., et al. The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study. Biol Psychiatry 2000, 48(4):287-293.
52. Bohne A., Wilhelm S., Keuthen N.J., Florin I., Baer L., Jenike M.A. Prevalence of body dysmorphic disorder in a German college student sample. Psychiatry Res 2002, 109(1):101-104.
53. Cansever A., Uzun O., Donmez E., Ozsahin A. The prevalence and clinical features of body dysmorphic disorder in college students: a study in a Turkish sample. Compr Psychiatry 2003, 44(1):60-64.
54. Faravelli C., Salvatori S., Galassi F., Aiazzi L., Drei C., Cabras P. Epidemiology of somatoform disorders: a community survey in Florence. Soc Psychiatry Psychiatr Epidemiol 1997, 32(1):24-29.
55. Otto M.W., Wilhelm S., Cohen L.S., Harlow B.L. Prevalence of body dysmorphic disorder in a community sample of women. Am J Psychiatry 2001, 158(12):2061-2063.
56. Sarwer D.B., Cash T.F., Magee L., Williams E.F., Thompson J.K., Roehrig M., et al. Female college students and cosmetic surgery: an investigation of experiences, attitudes, and body image. Plast Reconstr Surg 2005, 115(3):931-938.
57. Rief W., Buhlmann U., Wilhelm S., Borkenhagen A., Brahler E. The prevalence of body dysmorphic disorder: a population-based survey. Psychol Med 2006, 36(6):877-885.
58. Buhlmann U., Glaesmer H., Mewes R., Fama J.M., Wilhelm S., Brahler E., et al. Updates on the prevalence of body dysmorphic disorder: a population-based survey. Psychiatry Res 2010, 178:171-175.
59. Koran L.M., Abujaoude E., Large M.D., Serpe R.T. The prevalence of body dysmorphic disorder in the United States adult population. CNS Spectr 2008, 13(4):316-322.
60. Phillips K.A., McElroy S.L., Hudson J.I., Pope H.G. Body dysmorphic disorder: an obsessive-compulsive spectrum disorder, a form of affective spectrum disorder, or both?. J Clin Psychiatry 1995, 56(Suppl 4):41-51. [discussion 2].
61. Saxena S., Winograd A., Dunkin J.J., Maidment K., Rosen R., Vapnik T., et al. A retrospective review of clinical characteristics and treatment response in body dysmorphic disorder versus obsessive-compulsive disorder. J Clin Psychiatry 2001, 62(1):67-72. [quiz 3].
62. Simeon D., Hollander E., Stein D.J., Cohen L., Aronowitz B. Body dysmorphic disorder in the DSM-IV field trial for obsessive-compulsive disorder. Am J Psychiatry 1995, 152(8):1207-1209.
63. Pryse-Phillips W. An olfactory reference syndrome. Acta Psychiatr Scand 1971, 47(4):484-509.
64. Munro A., Mok H. An overview of treatment in paranoia/delusional disorder. Can J Psychiatry 1995, 40(10):616-622.
65. Stein D.J., Le Roux L., Bouwer C., Van Heerden B. Is olfactory reference syndrome an obsessive-compulsive spectrum disorder? Two cases and a discussion. J Neuropsychiatry Clin Neurosci 1998, 10(1):96-99.
66. Wada T., Kawakatsu S., Nadaoka T., Okuyama N., Otani K. Clomipramine treatment of delusional disorder, somatic type. Int Clin Psychopharmacol 1999, 14(3):181-183.
67. Phillips K.A., Castle D.J. How to help patients with olfactory reference syndrome. Curr Psychiatr 2008, 6(3):49-65.
68. Phillips K.A., Kim J.M., Hudson J.I. Body image disturbance in body dysmorphic disorder and eating disorders. Obsessions or delusions?. Psychiatr Clin North Am 1995, 18(2):317-334.
69. Grant J.E., Phillips K.A. Is anorexia nervosa a subtype of body dysmorphic disorder? Probably not, but read on. Harv Rev of Psychiatry 2004, 12(2):123-126.
70. Rosen J.C., Ramirez E. A comparison of eating disorders and body dysmorphic disorder on body image and psychological adjustment. J Psychosom Res 1998, 44(3-4):441-449.
71. Kaye W.H., Nagata T., Weltzin T.E., Hsu L.K., Sokol M.S., McConaha C., et al. Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa. Biol Psychiatry 2001, 49(7):644-652.
72. Walsh B.T., Kaplan A.S., Attia E., Olmsted M., Parides M., Carter J.C., et al. Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial. JAMA 2006, 295(22):2605-2612.
73. Schneier F.R., Blanco C., Antia S.X., Liebowitz M.R. The social anxiety spectrum. Psychiatr Clin North Am 2002, 25(4):757-774.
74. Lochner C., Stein D.J. Olfactory reference syndrome: diagnostic criteria and differential diagnosis. J Postgrad Med 2003, 49(4):328-331.
75. Kleinknecht R.A., Dinnel D.L., Kleinknecht E.E., Hiruma N., Harada N. Cultural factors in social anxiety: a comparison of social phobia symptoms and Taijin Kyofusho. J Anxiety Disord 1997, 11(2):157-177.
76. Nagata T., van Vliet I., Yamada H., Kataoka K., Iketani T., Kiriike N. An open trial of paroxetine for the " offensive subtype" of Taijin Kyofusho and social anxiety disorder. Depress Anxiety 2006, 23(3):168-174.
77. Malmivaara A., Kuukasjarvi P., Autti-Ramo I., Kovanen N., Makela M. Effectiveness and safety of endoscopic thoracic sympathectomy for excessive sweating and facial blushing: a systematic review. Int J Technol Assess Health Care 2007, 23(1):54-62.
78. Licht P.B., Ladegaard L., Pilegaard H.K. Thoracoscopic sympathectomy for isolated facial blushing. Ann Thorac Surg 2006, 81(5):1863-1866.
79. Adair A., George M.L., Camprodon R., Broadfield J.A., Rennie J.A. Endoscopic sympathectomy in the treatment of facial blushing. Ann R Coll Surg Engl 2005, 87(5):358-360.
80. Greeven A., van Balkom A.J., van der Leeden R., Merkelbach J.W., van den Heuvel O.A., Spinhoven P. Cognitive behavioral therapy versus paroxetine in the treatment of hypochondriasis: an 18-month naturalistic follow-up. J Behav Ther Exp Psychiatry 2009, 40(3):487-496.
81. Magarinos M., Zafar U., Nissenson K., Blanco C. Epidemiology and treatment of hypochondriasis. CNS Drugs 2002, 16(1):9-22.
82. Didie E.R., Tortolani C.C., Pope C.G., Menard W., Fay C., Phillips K.A. Childhood abuse and neglect in body dysmorphic disorder. Child Abuse Negl 2006, 30(10):1105-1115.
83. Neziroglu F., Khemlani-Patel S., Yaryura-Tobias J.A. Rates of abuse in body dysmorphic disorder and obsessive-compulsive disorder. Body Image 2006, 3(2):189-193.
84. Buhlmann U., Cook L.M., Fama J.M., Wilhelm S. Perceived teasing experiences in body dysmorphic disorder. Body Image 2007, 4(4):381-385.
85. Sarwer D.B., Crerand C.E. Body image and cosmetic medical treatments. Body Image 2004, 1(1):99-111.
86. Field A.E., Austin S.B., Camargo C.A., Taylor C.B., Striegel-Moore R.H., Loud K.J., et al. Exposure to the mass media, body shape concerns, and use of supplements to improve weight and shape among male and female adolescents. Pediatrics 2005, 116(2):e214-e220.
87. Cash T.F. Cognitive behavioral perspectives on body image. Body Image: a handbook of theory, research and clinical practice. 2002, Guilford Press, New York, p.38-46. T.F. Cash, T. Pruzinsky (Eds.).
88. Neziroglu F., Khemlani-Patel S., Veale D. Social learning theory and cognitive behavioral models of body dysmorphic disorder. Body Image 2008, 5(1):28-38.
89. Veale D., Ennis M., Lambrou C. Possible association of body dysmorphic disorder with an occupation or education in art and design. Am J Psychiatry 2002, 159(10):1788-1790.
90. Veale D. Advances in a cognitive behavioural model of body dysmorphic disorder. Body Image 2004, 1(1):113-125.
91. Feusner J.D., Yaryura-Tobias J., Saxena S. The pathophysiology of body dysmorphic disorder. Body Image 2008, 5(1):3-12.
92. Rauch S.L., Phillips K.A., Segal E., Makris N., Shin L.M., Whalen P.J., et al. A preliminary morphometric magnetic resonance imaging study of regional brain volumes in body dysmorphic disorder. Psychiatry Res 2003, 122(1):13-19.
93. Carey P., Seedat S., Warwick J., van Heerden B., Stein D.J. SPECT imaging of body dysmorphic disorder. J Neuropsychiatry Clin Neurosci 2004, 16(3):357-359.
94. Feusner J.D., Townsend J., Bystritsky A., McKinley M., Moller H., Bookheimer S. Regional brain volumes and symptom severity in body dysmorphic disorder. Psychiatry Res 2009, 172(2):161-167.
95. Feusner J.D., Moody T., Hembacher E., Townsend J., McKinley M., Moller H., et al. Abnormalities of visual processing and frontostriatal systems in body dysmorphic disorder. Arch Gen Psychiatry 2010, 67(2):197-205.
96. Allen A., Hadley S.J., Kaplan A., Simeon D., Friedberg J., Priday L., et al. An open-label trial of venlafaxine in body dysmorphic disorder. CNS Spectr 2008, 13(2):138-144.
97. Hollander E., Cohen L., Simeon D., Rosen J., DeCaria C., Stein D.J. Fluvoxamine treatment of body dysmorphic disorder. J Clin Psychopharmacol 1994, 14(1):75-77.
98. Perugi G., Giannotti D., Di Vaio S., Frare F., Saettoni M., Cassano G.B. Fluvoxamine in the treatment of body dysmorphic disorder (dysmorphophobia). Int Clin Psychopharmacol 1996, 11(4):247-254.
99. Phillips K.A. An open-label study of escitalopram in body dysmorphic disorder. Int Clin Psychopharmacol 2006, 21(3):177-179.
100. Phillips K.A., Dwight M.M., McElroy S.L. Efficacy and safety of fluvoxamine in body dysmorphic disorder. J Clin Psychiatry 1998, 59(4):165-171.
101. Phillips K.A., Najjar F. An open-label study of citalopram in body dysmorphic disorder. J Clin Psychiatry 2003, 64(6):715-720.
102. Hollander E., Allen A., Kwon J., Aronowitz B., Schmeidler J., Wong C., et al. Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Arch Gen Psychiatry 1999, 56(11):1033-1039.
103. Phillips K.A., Albertini R.S., Rasmussen S.A. A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Arch Gen Psychiatry 2002, 59(4):381-388.
104. Williams J., Hadjistavropoulos T., Sharpe D. A meta-analysis of psychological and pharmacological treatments for Body Dysmorphic Disorder. Behav Res Ther 2006, 44(1):99-111.
105. Phillips K.A., Hollander E. Treating body dysmorphic disorder with medication: evidence, misconceptions, and a suggested approach. Body Image 2008, 5(1):13-27.
106. Phillips K.A., Albertini R.S., Siniscalchi J.M., Khan A., Robinson M. Effectiveness of pharmacotherapy for body dysmorphic disorder: a chart: review study. J Clin Psychiatry 2001, 62(9):721-727.
107. Grant J.E. Successful treatment of nondelusional body dysmorphic disorder with olanzapine: a case report. J Clin Psychiatry 2001, 62(4):297-298.
108. Phillips K.A., Menard W. A prospective pilot study of levetiracetam for body dysmorphic disorder. CNS Spectr 2009, 14(5):252-260.
109. Phillips K.A. Olanzapine augmentation of fluoxetine in body dysmorphic disorder. Am J Psychiatry 2005, 162(5):1022-1023.
110. Phillips K.A. Placebo-controlled study of pimozide augmentation of fluoxetine in body dysmorphic disorder. Am J Psychiatry 2005, 162(2):377-379.
111. Nakaaki S., Murata Y., Furukawa T.A. Efficacy of olanzapine augmentation of paroxetine therapy in patients with severe body dysmorphic disorder. Psychiatry Clin Neurosci 2008, 62(3):370.
112. Rosen J.C., Reiter J., Orosan P. Cognitive behavioral body image therapy for body dysmorphic disorder. J Consult Clin Psychol 1995, 63(2):263-269.
113. Veale D., Gournay K., Dryden W., Boocock A., Shah F., Willson R., et al. Body dysmorphic disorder: a cognitive behavioural model and pilot randomized controlled trial. Behav Res Ther 1996, 34(9):717-729.
114. Veale D. Cognitive behaviour therapy for body dysmorphic disorder. Disorders of body image. 2002, Petersfield: Wrightson Biomedical, p.121-38. D. Castle, K. Phillips (Eds.).
115. Aouizerate B., Cuny E., Martin-Guehl C., Guehl D., Amieva H., Benazzouz A., et al. Deep brain stimulation of the ventral caudate nucleus in the treatment of obsessive-compulsive disorder and major depression. Case report. J Neurosurg 2004, 101(4):682-686.
116. Lakhan S.E., Callaway E. Deep brain stimulation for obsessive-compulsive disorder and treatment-resistant depression: systematic review. BMC Res Notes 2010, 3:60.
117. Phillips K.A., Grant J., Siniscalchi J., Albertini R.S. Surgical and nonpsychiatric medical treatment of patients with body dysmorphic disorder. Psychosomatics 2001, 42(6):504-510.
118. Crerand C.E., Franklin M.E., Sarwer D.B. Body dysmorphic disorder and cosmetic surgery. Plast Reconstr Surg 2006, 118(7):167e-180e.
119. Ende K.H., Lewis D.L., Kabaker S.S. Body dysmorphic disorder. Facial Plast Surg Clin North Am 2008, 16(2):217-223. [vii].
120. Jakubietz M., Jakubietz R.J., Kloss D.F., Gruenert J.J. Body dysmorphic disorder: diagnosis and approach. Plast Reconstr Surg 2007, 119(6):1924-1930.
121. Pavan C., Simonato P., Marini M., Mazzoleni F., Pavan L., Vindigni V. Psychopathologic aspects of body dysmorphic disorder: a literature review. Aesthetic Plast Surg 2008, 32(3):473-484.
122. Sarwer D.B. Awareness and identification of body dysmorphic disorder by aesthetic surgeons: results of a survey of American Society for Aesthetic Plastic Surgery Members. Aesthetic Surg J 2002, 22:531-535.
123. Veale D., De Haro L., Lambrou C. Cosmetic rhinoplasty in body dysmorphic disorder. Br J Plast Surg 2003, 56(6):546-551.
124. Tignol J., Biraben-Gotzamanis L., Martin-Guehl C., Grabot D., Aouizerate B. Body dysmorphic disorder and cosmetic surgery: evolution of 24subjects with a minimal defect in appearance 5years after their request for cosmetic surgery. Eur Psychiatry 2007, 22(8):520-524.
125. Thompson C.M., Durrani A.J. An increasing need for early detection of body dysmorphic disorder by all specialties. J R Soc Med 2007, 100(2):61-62.
126. Dufresne R.G., Phillips K.A., Vittorio C.C., Wilkel C.S. A screening questionnaire for body dysmorphic disorder in a cosmetic dermatologic surgery practice. Dermatol Surg 2001, 27(5):457-462.
127. Nierenberg A.A., Phillips K.A., Petersen T.J., Kelly K.E., Alpert J.E., Worthington J.J., et al. Body dysmorphic disorder in outpatients with major depression. J Affect Disord 2002, 69(1-3):141-148.
128. Phillips K.A., Hollander E., Rasmussen S.A., Aronowitz B.R., DeCaria C., Goodman W.K. A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive-Compulsive Scale. Psychopharmacol Bull 1997, 33(1):17-22.
129. Sarwer D.B., Zanville H.A., LaRossa D., Bartlett S.P., Chang B., Low D.W., et al. Mental health histories and psychiatric medication usage among persons who sought cosmetic Surgery. Plast Reconstr Surg 2004, 114(7):1927-1933. [discussion 34-35].
130. Veale D. Outcome of cosmetic surgery and " DIY" surgery in patients with Body Dysmorphic Disorder. Psychiatr Bull 2000, 24:218-220.
131. Altamura C., Paluello M.M., Mundo E., Medda S., Mannu P. Clinical and subclinical body dysmorphic disorder. Eur Arch Psychiatry Clin Neurosci 2001, 251(3):105-108.